QBRELIS

PeakSM

lisinopril

NDAORALSOLUTION
Approved
Jul 2016
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
19

Clinical Trials (5)

NCT06772779Phase 1Completed

A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)

Started Apr 2024
36 enrolled
Healthy
NCT02070510Phase 1Completed

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

Started Feb 2014
52 enrolled
DiabetesHealthy
NCT01398267Phase 1Completed

A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril

Started Aug 2011
55 enrolled
Diabetes Mellitus Type 2
NCT01126697Phase 2/3Completed

Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies

Started Feb 2010
63 enrolled
Duchenne Muscular DystrophyBecker Muscular DystrophyLimb Girdle Muscular Dystrophy
NCT00657241Phase 3Completed

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

Started Apr 2008
30 enrolled
Hypertension

Loss of Exclusivity

LOE Date
Nov 6, 2035
117 months away
Patent Expiry
Nov 6, 2035

Patent Records (5)

Patent #ExpiryTypeUse Code
10039800
Nov 6, 2035
U-185
10265370
Nov 6, 2035
Product
10406199
Nov 6, 2035
U-8
10940177
Nov 6, 2035
Product
11179434
Nov 6, 2035
Product